Kelly Schick

CIK: 0001797388

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (33.3%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)6 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CCCC

C4 Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

CCCC
C4 Therapeutics, Inc.
Feb 14, 2026
Tax Payment(F)
Direct
7.3K shares at avg. $1.89$14K
CCCC
C4 Therapeutics, Inc.
Feb 14, 2026
Exercise(M)
Direct
21K shares-
CCCC
C4 Therapeutics, Inc.
Feb 13, 2026
Award(A)
Direct
200K shares-
CCCC
C4 Therapeutics, Inc.
Feb 13, 2026
Exercise(M)
Direct
5K shares-
CCCC
C4 Therapeutics, Inc.
Feb 13, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $1.89$3K
CCCC
C4 Therapeutics, Inc.
Feb 14, 2025
Tax Payment(F)
Direct
2.4K shares at avg. $3.18$8K
CCCC
C4 Therapeutics, Inc.
Feb 14, 2025
Award(A)
Direct
56.5K shares-
CCCC
C4 Therapeutics, Inc.
Feb 13, 2025
Tax Payment(F)
Direct
1.7K shares at avg. $3.20$6K
CCCC
C4 Therapeutics, Inc.
Nov 7, 2024
Exercise(M)
Direct
3.8K shares-
CCCC
C4 Therapeutics, Inc.
Nov 7, 2024
Tax Payment(F)
Direct
1.1K shares at avg. $6.04$7K
CCCC
C4 Therapeutics, Inc.
Sep 16, 2024
Exercise(M)
Direct
2.3K shares-
CCCC
C4 Therapeutics, Inc.
Sep 16, 2024
Tax Payment(F)
Direct
661 shares at avg. $6.36$4K

		Type	Shares	Price		Ownership
Feb 14, 2026	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	7,269	$1.89	$13,738	Direct
Feb 14, 2026	CCCC C4 Therapeutics, Inc.	Exercise(M)	20,950	-	$0	Direct
Feb 13, 2026	CCCC C4 Therapeutics, Inc.	Award(A)	200,000	-	$0	Direct
Feb 13, 2026	CCCC C4 Therapeutics, Inc.	Exercise(M)	5,000	-	$0	Direct
Feb 13, 2026	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	1,735	$1.89	$3,279	Direct
Feb 14, 2025	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	2,368	$3.18	$7,530	Direct
Feb 14, 2025	CCCC C4 Therapeutics, Inc.	Award(A)	56,500	-	-	Direct
Feb 13, 2025	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	1,735	$3.20	$5,552	Direct
Nov 7, 2024	CCCC C4 Therapeutics, Inc.	Exercise(M)	3,750	-	$0	Direct
Nov 7, 2024	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	1,102	$6.04	$6,656	Direct
Sep 16, 2024	CCCC C4 Therapeutics, Inc.	Exercise(M)	2,250	-	$0	Direct
Sep 16, 2024	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	661	$6.36	$4,204	Direct

1-12 of 12 transactions

About Schick Kelly

Schick Kelly (SEC CIK 0001797388) files insider reports with the SEC as Chief People Officer of C4 Therapeutics, Inc. (CCCC).

Signal8 holds 4 ownership filings by Schick Kelly, all Form 4s, filed between Sep 17, 2024 and Feb 18, 2026. Those filings report 12 transactions, from Sep 16, 2024 to Feb 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schick Kelly's filings is in WATERTOWN, MA.

Recent filings by Schick Kelly

Feb 14, 2026: Tax withholding of CCCC shares (Form 4, code F).
Feb 14, 2026: Option exercise of CCCC shares (Form 4, code M).
Feb 13, 2026: Grant or award of CCCC shares (Form 4, code A).
Feb 13, 2026: Option exercise of CCCC shares (Form 4, code M).
Feb 13, 2026: Tax withholding of CCCC shares (Form 4, code F).

Other insiders filing for C4 Therapeutics, Inc. (CCCC)

Anderson Kenneth Carl, Director
GROGAN DONNA ROY, Director
Adams Kendra, Chief Financial Officer
REYNO LEONARD, Chief Medical Officer
Hughes Owen, Director
Hoerter Steven L., Director

How to read Form 4 transaction codes